MTOR-driven quasi-programmed aging as a disposable soma theory Blind watchmaker vs. intelligent designer

Cell Cycle

Volumn 12, Issue 12, 2013, Pages 1842-1847

  Blagosklonny, Mikhail V ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Cancer; Diseases; God; Natural selection; Rapamycin; Senescence

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN;

ARTICLE; CELL AGING; CELL DAMAGE; CELL GROWTH; DISPOSABLE SOMA THEORY; EATING; HOMEOSTASIS; HUMAN; LIFE; LIFESPAN; MORTALITY; MUTATION; NONHUMAN; THEORY;

EID: 84879355032     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.25062     Document Type: Article

References (92)

1. Dawkins R. ISBN Ê 0-393-31570-3. The Blind Watchmaker. New York: W. W. Norton & Company, Inc; 1986.
2. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471-84; PMID:16469695; http://dx.doi.org/10.1016/j. cell.2006.01.016 (Pubitemid 43199434)
3. Loewith R, Hall MN. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 2011; 189:1177-201; PMID:22174183; http://dx.doi.org/ 10.1534/genetics.111.133363
4. Mounier R, Lantier L, Leclerc J, Sotiropoulos A, Foretz M, Viollet B. Antagonistic control of muscle cell size by AMPK and mTORC1. Cell Cycle 2011; 10:2640-6; PMID:21799304; http://dx.doi.org/10.4161/cc.10.16.17102
5. Dreesen IA, Fussenegger M. Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cells. Biotechnol Bioeng 2011; 108:853-66; PMID:21404259; http://dx.doi.org/10.1002/bit.22990
6. Blagosklonny MV. Answering the ultimate question "what is the proximal cause of aging?". Aging (Albany NY) 2012; 4:861-77; PMID:23425777
7. Blagosklonny MV. Big mice die young but large animals live longer. Aging (Albany NY) 2013; 5:227-33; PMID:23603822
8. Hansen M, Taubert S, Crawford D, Libina N, Lee SJ, Kenyon C. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 2007; 6:95-110; PMID:17266679; http://dx.doi.org/10.1111/j.1474-9726. 2006.00267.x (Pubitemid 46140143)
9. Pan KZ, Palter JE, Rogers AN, Olsen A, Chen D, Lithgow GJ, et al. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 2007; 6:111-9; PMID:17266680; http://dx.doi.org/10.1111/j.1474-9726.2006. 00266.x (Pubitemid 46140144)
10. Syntichaki P, Troulinaki K, Tavernarakis N. eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans. Nature 2007; 445:922-6; PMID:17277769; http://dx.doi.org/10.1038/nature05603
11. Hansen M, Taubert S, Crawford D, Libina N, Lee SJ, Kenyon C. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 2007; 6:95-110; PMID:17266679; http://dx.doi.org/10.1111/j.1474-9726. 2006.00267.x (Pubitemid 46140143)
12. Tavernarakis N. Protein synthesis and aging: EIF4E and the soma vs. germline distinction. Cell Cycle 2007; 6:1168-71; PMID:17495543; http://dx.doi.org/10.4161/cc.6.10.4230 (Pubitemid 47327982)
13. Mehta R, Chandler-Brown D, Ramos FJ, Shamieh LS, Kaeberlein M. Regulation of mRNA translation as a conserved mechanism of longevity control. Adv Exp Med Biol 2010; 694:14-29; PMID:20886753; http://dx.doi.org/10.1007/978-1-4419-7002- 2-2
14. Blagosklonny MV. Paradoxes of aging. Cell Cycle 2007; 6:2997-3003; PMID:18156807; http://dx.doi.org/10.4161/cc.6.24.5124
15. Kirkwood T. Why women live longer. Stress alone does not explain the longevity gap. Sci Am 2010; 303:34-5; PMID:21033280; http://dx.doi.org/10.1038/ scientificamerican1110-34
16. Blagosklonny MV. TOR-driven aging: Speeding car without brakes. Cell Cycle 2009; 8:4055-9; PMID:19923900; http://dx.doi.org/10.4161/cc.8.24.10310
17. Kirkwood TB, Austad SN. Why do we age? Nature 2000; 408:233-8; PMID:11089980; http://dx.doi.org/10.1038/35041682
18. Kirkwood TB. Understanding the odd science of aging. Cell 2005; 120:437-47; PMID:15734677; http://dx.doi.org/10.1016/j.cell.2005.01.027 (Pubitemid 40269759)
19. Blagosklonny MV. Why the disposable soma theory cannot explain why women live longer and why we age. Aging (Albany NY) 2010; 2:884-7; PMID:21191147
20. Blagosklonny MV. Hormesis does not make sense except in the light of TOR-driven aging. Aging (Albany NY) 2011; 3:1051-62; PMID:22166724
21. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993; 366:461-4; PMID:8247153; http://dx.doi.org/10.1038/366461a0 (Pubitemid 24013878)
22. Guarente L, Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 2000; 408:255-62; PMID:11089983; http://dx.doi.org/10.1038/ 35041700
23. Bartke A, Coschigano K, Kopchick J, Chandrashekar V, Mattison J, Kinney B, et al. Genes that prolong life: Relationships of growth hormone and growth to aging and lifespan. J Gerontol A Biol Sci Med Sci 2001; 56:B340-9; PMID:11487592; http://dx.doi.org/10.1093/gerona/56.8.B340 (Pubitemid 32717780)
24. Ayyadevara S, Alla R, Thaden JJ, Shmookler Reis RJ. Remarkable longevity and stress resistance of nematode PI3K-null mutants. Aging Cell 2008; 7:13-22; PMID:17996009; http://dx.doi.org/10.1111/j.1474-9726.2007.00348.x
25. Broughton SJ, Piper MD, Ikeya T, Bass TM, Jacobson J, Driege Y, et al. Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc Natl Acad Sci USA 2005; 102:3105-10; PMID:15708981; http://dx.doi.org/10.1073/pnas.0405775102 (Pubitemid 40299923)
26. Borrás C, Monleón D, López-Grueso R, Gambini J, Orlando L, Pallardó FV, et al. RasGrf1 deficiency delays aging in mice. Aging (Albany NY) 2011; 3:262-76; PMID:21422498
27. Shmookler Reis RJ, Xu L, Lee H, Chae M, Thaden JJ, Bharill P, et al. Modulation of lipid biosynthesis contributes to stress resistance and longevity of C. elegans mutants. Aging (Albany NY) 2011; 3:125-47; PMID:21386131
28. Pinkston JM, Garigan D, Hansen M, Kenyon C. Mutations that increase the lifespan of C. elegans inhibit tumor growth. Science 2006; 313:971-5; PMID:16917064; http://dx.doi.org/10.1126/science. 1121908 (Pubitemid 44267389)
29. Haselton A, Sharmin E, Schrader J, Sah M, Poon P, Fridell YW. Partial ablation of adult Drosophila insulin-producing neurons modulates glucose homeostasis and extends lifespan without insulin resistance. Cell Cycle 2010; 9:3063-71; PMID:20699643; http://dx.doi.org/10.4161/cc.9.15.12458
30. Streeper RS, Grueter CA, Salomonis N, Cases S, Levin MC, Koliwad SK, et al. Deficiency of the lipid synthesis enzyme, DGAT1, extends longevity in mice. Aging (Albany NY) 2012; 4:13-27; PMID:22291164
31. Zhou KI, Pincus Z, Slack FJ. Longevity and stress in Caenorhabditis elegans. Aging (Albany NY) 2011; 3:733-53; PMID:21937765
32. Kapahi P, Chen D, Rogers AN, Katewa SD, Li PW, Thomas EL, et al. With TOR, less is more: A key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab 2010; 11:453-65; PMID:20519118; http://dx.doi.org/10.1016/j. cmet.2010.05.001
33. Katewa SD, Kapahi P. Role of TOR signaling in aging and related biological processes in Drosophila melanogaster. Exp Gerontol 2011; 46:382-90; PMID:21130151; http://dx.doi.org/10.1016/j.exger.2010.11.036
34. Sharp ZD. Aging and TOR: Interwoven in the fabric of life. Cell Mol Life Sci 2011; 68:587-97; PMID:20960025; http://dx.doi.org/10.1007/s00018-010-0542-0
35. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian lifespan. Science 2009; 326:140-4; PMID:19797661; http://dx.doi.org/10.1126/science.1177221
36. Selman C, Partridge L. A double whammy for aging? Rapamycin extends lifespan and inhibits cancer in inbred female mice. Cell Cycle 2012; 11:17-8; PMID:22186783; http://dx.doi.org/10.4161/cc.11.1.18736
37. Blagosklonny MV. Rapamycin and quasi-programmed aging: Four years later. Cell Cycle 2010; 9:1859-62; PMID:20436272; http://dx.doi.org/10.4161/cc.9.10. 11872
38. Blagosklonny MV. Answering the ultimate question "what is the proximal cause of aging?" Aging (Albany NY) 2012; 4:861-77; PMID:23425777
39. Gems DH, Guardia YD. Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction? Antioxid Redox Signal 2012; PMID:22870907; http://dx.doi.org/10.1089/ars.2012.4840
40. Kaeberlein TL, Smith ED, Tsuchiya M, Welton KL, Thomas JH, Fields S, et al. Lifespan extension in Caenorhabditis elegans by complete removal of food. Aging Cell 2006; 5:487-94; PMID:17081160; http://dx.doi.org/10.1111/j.1474-9726. 2006.00238.x (Pubitemid 44782617)
41. Blagosklonny MV, Hall MN. Growth and aging: A common molecular mechanism. Aging (Albany NY) 2009; 1:357-62; PMID:20157523
42. Blagosklonny MV. Aging and immortality: Quasi-programmed senescence and its pharmacologic inhibition. Cell Cycle 2006; 5:2087-102; PMID:17012837; http://dx.doi.org/10.4161/cc.5.18.3288 (Pubitemid 44566240)
43. Blagosklonny MV. Prospective treatment of agerelated diseases by slowing down aging. Am J Pathol 2012; 181:1142-6; PMID:22841821; http://dx.doi.org/10. 1016/j.ajpath.2012.06.024
44. Blagosklonny MV. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: Terminology for TOR-driven aging. Aging (Albany NY) 2012; 4:159-65; PMID:22394614
45. Demidenko ZN, Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008; 7:3355-61; PMID:18948731; http://dx.doi.org/10.4161/cc.7.21.6919
46. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888-95; PMID:19471117; http://dx.doi.org/10.4161/cc.8.12.8606
47. Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:4112-8; PMID:19946210; http://dx.doi.org/10.4161/cc.8.24.10215
48. Wang CY, Kim HH, Hiroi Y, Sawada N, Salomone S, Benjamin LE, et al. Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. Sci Signal 2009; 2:ra11; PMID:19293429; http://dx.doi.org/10.1126/scisignal.2000143
49. Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 2010; 107:9660-4; PMID:20457898; http://dx.doi.org/10.1073/pnas.1002298107
50. Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344-52; PMID:20606252
51. Leontieva OV, Blagosklonny MV. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging (Albany NY) 2010; 2:924-35; PMID:21212465
52. Leontieva OV, Natarajan V, Demidenko ZN, Burdelya LG, Gudkov AV, Blagosklonny MV. Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc Natl Acad Sci USA 2012; 109:13314-8; PMID:22847439; http://dx.doi.org/10.1073/pnas.1205690109
53. Leontieva OV, Lenzo F, Demidenko ZN, Blagosklonny MV. Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Cell Cycle 2012; 11:4642-9; PMID:23187803; http://dx.doi.org/10.4161/cc.22937
54. Cho S, Hwang ES. Status of mTOR activity may phenotypically differentiate senescence and quiescence. Mol Cells 2012; 33:597-604; PMID:22570149; http://dx.doi.org/10.1007/s10059-012-0042-1
55. Kolesnichenko M, Hong L, Liao R, Vogt PK, Sun P. Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence. Cell Cycle 2012; 11:2391-401; PMID:22627671; http://dx.doi.org/10.4161/cc.20683
56. Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, et al. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: Chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. Am J Pathol 2012; 181:278-93; PMID:22698676; http://dx.doi.org/10.1016/j.ajpath.2012. 03.017
57. Halicka HD, Zhao H, Li J, Lee YS, Hsieh TC, Wu JM, et al. Potential anti-aging agents suppress the level of constitutive mTOR-and DNA damage-signaling. Aging (Albany NY) 2012; 4:952-65; PMID:23363784
58. Denchi EL. A critical role for TORC1 in cellular senescence. Cell Cycle 2012; 11:2976; PMID:22874595; http://dx.doi.org/10.4161/cc.21529
59. Iglesias-Bartolome R, Gutkind SJ. Exploiting the mTOR paradox for disease prevention. Oncotarget 2012; 3:1061-3; PMID:23165441
60. Darzynkiewicz Z. Running m(o)TOR with the brakes on leads to catastrophe at mitosis. Cell Cycle 2012; 11:4494; PMID:23222065; http://dx.doi.org/10.4161/ cc.22932
61. Wang M, Miller RA. Fibroblasts from long-lived mutant mice exhibit increased autophagy and lower TOR activity after nutrient deprivation or oxidative stress. Aging Cell 2012; 11:668-74; PMID:22577861; http://dx.doi.org/10.1111/j.1474-9726.2012.00833.x
62. Powers RW 3rd, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S. Extension of chronological lifespan in yeast by decreased TOR pathway signaling. Genes Dev 2006; 20:174-84; PMID:16418483; http://dx.doi.org/10.1101/gad.1381406 (Pubitemid 43112936)
63. Leontieva OV, Blagosklonny MV. Yeast-like chronological senescence in mammalian cells: Phenomenon, mechanism and pharmacological suppression. Aging (Albany NY) 2011; 3:1078-91; PMID:22156391
64. Burtner CR, Murakami CJ, Kennedy BK, Kaeberlein M. A molecular mechanism of chronological aging in yeast. Cell Cycle 2009; 8:1256-70; PMID:19305133; http://dx.doi.org/10.4161/cc.8.8.8287
65. Kaeberlein M, Kennedy BK. A new chronological survival assay in mammalian cell culture. Cell Cycle 2012; 11:201-2; PMID:22214665; http://dx.doi.org/10. 4161/cc.11.2.18959
66. Pospelova TV, Leontieva OV, Bykova TV, Zubova SG, Pospelov VA, Blagosklonny MV. Suppression of replicative senescence by rapamycin in rodent embryonic cells. Cell Cycle 2012; 11:2402-7; PMID:22672902; http://dx.doi.org/ 10.4161/cc.20882
67. Serrano M. Dissecting the role of mTOR complexes in cellular senescence. Cell Cycle 2012; 11:2231-2; PMID:22714590; http://dx.doi.org/10.4161/cc.21065
68. Polymenis M, Kennedy BK. Chronological and replicative lifespan in yeast: Do they meet in the middle? Cell Cycle 2012; 11:3531-2; PMID:22951539; http://dx.doi.org/10.4161/cc.22041
69. Kolosova NG, Muraleva NA, Zhdankina AA, Stefanova NA, Fursova AZ, Blagosklonny MV. Prevention of age-related macular degeneration-like retinopathy by rapamycin in rats. Am J Pathol 2012; 181:472-7; PMID:22683466; http://dx.doi.org/10.1016/j.ajpath.2012.04.018
70. Zheng XF. Chemoprevention of age-related macular regeneration (AMD) with rapamycin. Aging (Albany NY) 2012; 4:375-6; PMID:22796653
71. Yang SB, Tien AC, Boddupalli G, Xu AW, Jan YN, Jan LY. Rapamycin ameliorates age-dependent obesity associated with increased mTOR signaling in hypothalamic POMC neurons. Neuron 2012; 75:425-36; PMID:22884327; http://dx.doi.org/10.1016/j.neuron.2012.03.043
72. Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013; 493:338-45; PMID:23325216; http://dx.doi.org/10.1038/nature11861
73. Passtoors WM, Beekman M, Deelen J, van der Breggen R, Maier AB, Guigas B, et al. Gene expression analysis of mTOR pathway: Association with human longevity. Aging Cell 2013; 12:24-31; PMID:23061800; http://dx.doi.org/10.1111/ acel.12015
74. Halloran J, Hussong SA, Burbank R, Podlutskaya N, Fischer KE, Sloane LB, et al. Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience 2012; 223:102-13; PMID:22750207; http://dx.doi.org/10. 1016/j.neuroscience.2012.06.054
75. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460:392-5; PMID:19587680
76. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin extends maximal lifespan in cancer-prone mice. Am J Pathol 2010; 176:2092-7; PMID:20363920; http://dx.doi.org/10.2353/ajpath.2010. 091050
77. Komarova EA, Antoch MP, Novototskaya LR, Chernova OB, Paszkiewicz G, Leontieva OV, et al. Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/-mice. Aging (Albany NY) 2012; 4:709-14; PMID:23123616
78. Comas M, Toshkov I, Kuropatwinski KK, Chernova OB, Polinsky A, Blagosklonny MV, et al. New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/-mice by delaying carcinogenesis. Aging (Albany NY) 2012; 4:715-22; PMID:23117593
79. Donehower LA. Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency. Aging (Albany NY) 2012; 4:660-1; PMID:23128359
80. Levine AJ, Harris CR, Puzio-Kuter AM. The interfaces between signal transduction pathways: IGF-1/mTor, p53 and the Parkinson Disease pathway. Oncotarget 2012; 3:1301-7; PMID:23211569
81. Livi CB, Hardman RL, Christy BA, Dodds SG, Jones D, Williams C, et al. Rapamycin extends lifespan of Rb1+/-mice by inhibiting neuroendocrine tumors. Aging (Albany NY) 2013; 5:100-10; PMID:23454836
82. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, et al. Rapamycin slows aging in mice. Aging Cell 2012; 11:675-82; PMID:22587563; http://dx.doi.org/10.1111/j.1474-9726.2012.00832.x
83. Spong A, Bartke A. Rapamycin slows aging in mice. Cell Cycle 2012; 11:845; PMID:22356747; http://dx.doi.org/10.4161/cc.11.5.19607
84. Dreesen O, Stewart CL. Accelerated aging syndromes, are they relevant to normal human aging? Aging (Albany NY) 2011; 3:889-95; PMID:21931180
85. Lachapelle S, Oesterreich S, Lebel M. The Werner syndrome helicase protein is required for cell proliferation, immortalization, and tumorigenesis in Scaffold attachment factor B1 deficient mice. Aging (Albany NY) 2011; 3:277-90; PMID:21464516
86. Pichierri P, Ammazzalorso F, Bignami M, Franchitto A. The Werner syndrome protein: Linking the replication checkpoint response to genome stability. Aging (Albany NY) 2011; 3:311-8; PMID:21389352
87. Damerla RR, Knickelbein KE, Strutt S, Liu FJ, Wang H, Opresko PL. Werner syndrome protein suppresses the formation of large deletions during the replication of human telomeric sequences. Cell Cycle 2012; 11:3036-44; PMID:22871734; http://dx.doi.org/10.4161/cc.21399
88. Gordon LB, McCarten KM, Giobbie-Hurder A, Machan JT, Campbell SE, Berns SD, et al. Disease progression in Hutchinson-Gilford progeria syndrome: Impact on growth and development. Pediatrics 2007; 120:824-33; PMID:17908770; http://dx.doi.org/10.1542/peds.2007-1357 (Pubitemid 47549571)
89. Blagosklonny MV. Progeria, rapamycin and normal aging: Recent breakthrough. Aging (Albany NY) 2011; 3:685-91; PMID:21743107
90. Ramos FJ, Chen SC, Garelick MG, Dai DF, Liao CY, Schreiber KH, et al. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci Transl Med 2012; 4:ra103; PMID:22837538; http://dx.doi.org/10.1126/scitranslmed. 3003802
91. Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med 2011; 3:89ra58; PMID:21715679; http://dx.doi.org/10.1126/scitranslmed.3002346
92. Blagosklonny MV. Molecular damage in cancer: An argument for mTOR-driven aging. Aging (Albany NY) 2011; 3:1130-41; PMID:22246147